A handpicked portfolio of highly pure extracts, clinical-grade supplements, and specialized pharmaceutical services.
A professional supplier of high-end pharmaceutical and nutritional solutions based in China, catering to clinical requirements globally.
For nearly 10 years, Jiangxi Serum Pharma Industries Co., Ltd. has been dedicated to exporting premium biological products, vaccines, Western medicines, active pharmaceutical ingredients (APIs), intermediates, medical consumables, food additives, and plant extracts. Over a decade of deep involvement in international export markets has granted us rich regulatory experience and logistics capability to guarantee reliable product quality and efficient distribution.
By prioritizing clinical validation, rigorous batch consistency testing, and strict compliance with USP, EP, and GMP specifications, we provide developers and manufacturing sites with unparalleled confidence in their global raw material procurement pipelines.
Explore Corporate HistoryA comprehensive study on the extraction techniques, pharmacological significance, global trade landscapes, and standardization requirements of Proanthocyanidins (PACs).
The commercial utilization of Cranberry Fruit Extract (derived from Vaccinium macrocarpon) has transitioned from traditional dietary supplements into highly standardized medical-grade ingredients. Historically restricted to North American markets where raw cranberry cultivation is concentrated (primarily across the United States and Canada), the demand has skyrocketed across the Asia-Pacific region, Europe, and Latin America. As global aging populations rise and consumer awareness shifts from treatment to prevention, Cranberry Fruit Extract has solidified its position as the premier natural ingredient for Urinary Tract Infection (UTI) prevention.
Today, the extract is prized not just as a bulk agricultural product, but as a specialized biochemical isolate containing high percentages of Proanthocyanidins (PACs). The global market valuation of cranberry derivatives is projected to grow exponentially, driven by pharmaceutical companies looking to reduce antibiotic dependency (specifically targeting the mitigation of bacterial resistance to standard treatments like Ciprofloxacin).
The most prominent trend shaping the cranberry extract supply chain is the strict insistence on the **A-Type Proanthocyanidins** quantification. Unlike other plants containing B-type PACs (such as grape seed or cocoa), cranberries are uniquely rich in A-type linkages, which are the exact phytochemical structures capable of preventing *Escherichia coli* from adhering to urothelial cells.
Historically, standardization was plagued by analytical inconsistencies. Suppliers used the **BL-DMAC** spectrophotometric method, the **USP** method, or liquid chromatography (**HPLC**), leading to wildly divergent results (for instance, a product labeled "25% PACs" by one method could register as "7% PACs" under another). Modern industry leaders have unified under strict standard protocols. Reputable suppliers now provide comprehensive chromatography certificates of analysis (CoAs) utilizing standard DMAC assay kits to verify the exact anti-adhesion threshold (usually a minimum dose of 36mg of A-type PACs per daily serving).
Industrial clients require customizable delivery formats to adapt to highly distinct local target demographics:
The manufacturing roadmap of plant extracts is shifting from solvent-intensive maceration to clean-label technologies. Supercritical CO2 extraction, membrane separation, and ultrafiltration techniques are replacing ethanol-water extraction pipelines to yield higher concentrations of polyphenols without heavy solvent residues.
Furthermore, the future lies in **synergistic pre-mix solutions**. By combining cranberry fruit extracts with advanced bioactive compounds, developers can address multi-faceted physiological pathways:
Our premium products will bring back the health. Formulated under strict GMP regulations to guarantee maximum therapeutic efficacy.
Our pharmaceutical products consist of biological products, vaccines, western medicines, raw materials, intermediates, and medical consumables, with high quality and affordable prices.
Derives From The Nature To Maintain Body Health And Balance With Purity
Our nutritional ingredients cover several categories as plant extracts, plant oils & proteins, probiotics, and other specialties. We are committed to exploring more health ingredients to support people's health.
View Full Catalog
Serum Pharma continuously monitors the development of cutting-edge markets. We cooperate with global partners on customization processes:
Homogeneous blending of active nutrients and microelements to streamline functional drink and tablet production lines.
Read More →
Advanced crystal matrix embedding to boost chemical stability, mask bitter tastes, and enhance target ingredient solubility.
Read More →
Harnessing microbial pathways to generate high-bioavailability compounds, clean-label postbiotics, and enzymes.
Read More →Stay informed with current scientific breakdowns, market analyses, and pipeline updates from the pharma and dietary sectors.
Discover how plant-derived alternatives are displacing shark liver oils, driven by sustainability standards and regulatory guidelines in cosmetic and vaccine adjuvants.
Analyzing the clinical demand, production dynamics, and supply chain longevity of this vital anti-inflammatory API in modern emergency medicine.
FDA officially approved the world's first and only oral GLP1 weight-loss drug without dietary restrictions under a rapid 50-day approval process, reshaping global peptide pipelines.
Scientific answers regarding quality metrics, standard compliance, and operational applications of Cranberry Fruit Extract.
Explore our complete export list, featuring GMP certified pharmaceutical formulations, antibiotic products, and therapeutic injections.
